Patent Assignment
Reel/Frame 067282/0585
Assignment of Assignor's Interest
Recorded: 2024-05-01
Pages: 5
Assignor
WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
Executed: 2024-04-09
Assignee
SHANGHAI ABELZETA LTD.
BUILDING 3, NO.85 FALADI ROAD, CHINA (SHANGHAI) PILOT FREE TRADE ZONE, SHANGHAI, CHINA
Covered Property
(1)
CD22-Targeted Chimeric Antigen Receptor, Preparation Method Therefor and Application Thereof
Application:
17/918,414 →
Publication:
US 2023/0144447
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 12, 2022
From: YAO, YIHONG; ZHU, LIN; LI, YANFENG; WEI, YUTIAN
To: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.; WUXI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
Reel/Frame 061393/0881 →
Change of Name
Apr 16, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067128/0044 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 67128 Frame: 44. Assignor(S) Hereby Confirms the Change of Name.
May 7, 2024
From: SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.
To: SHANGHAI ABELZETA LTD.
Reel/Frame 067334/0083 →